Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Lucira Health stock | $4.94

Learn how to easily invest in Lucira Health stock.

Lucira Health, Inc
NASDAQ: LHDX - USD
DIAGNOSTICS & RESEARCH
$0
-

Lucira Health, an Emeryville, California-based company that develops infectious disease test kits, completed an upsized IPO for $153 million, selling 9 million shares at $17 each.

Shares of LHDX opened at $22.10 and climbed more than 31% in early trading.

How to buy shares in Lucira Health

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LHDX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Lucira Health stock price (NASDAQ: LHDX)

Use our graph to track the performance of LHDX stocks over time.

Lucira Health shares at a glance

Information last updated 2021-07-28.
Latest market close$4.94
52-week range$4.23 - $37.99
50-day moving average $6.31
200-day moving average $10.75
Wall St. target price$8.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Lucira Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Lucira Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lucira Health price performance over time

Historical closes compared with the close of $4.94 from 2021-05-28

1 week (2021-07-23) N/A
1 month (2021-07-02) -26.71%
3 months (2021-05-03) -17.39%
6 months (2021-01-30) N/A
1 year (2020-07-30) N/A
2 years (2019-07-30) N/A
3 years (2018-07-30) N/A
5 years (2016-07-30) N/A

Lucira Health financials

Revenue TTM $4.8 million
Gross profit TTM $-1,672,000
Return on assets TTM -39.78%
Return on equity TTM -116.59%
Profit margin 0%
Book value $5.99
Market capitalisation $363.7 million

TTM: trailing 12 months

Shorting Lucira Health shares

There are currently 1.7 million Lucira Health shares held short by investors – that's known as Lucira Health's "short interest". This figure is 30.1% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting Lucira Health shares can be evaluated.

Lucira Health's "short interest ratio" (SIR)

Lucira Health's "short interest ratio" (SIR) is the quantity of Lucira Health shares currently shorted divided by the average quantity of Lucira Health shares traded daily (recently around 1.2 million). Lucira Health's SIR currently stands at 1.47. In other words for every 100,000 Lucira Health shares traded daily on the market, roughly 1470 shares are currently held short.

To gain some more context, you can compare Lucira Health's short interest ratio against those of similar companies.

However Lucira Health's short interest can also be evaluated against the total number of Lucira Health shares, or, against the total number of tradable Lucira Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lucira Health's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Lucira Health shares in existence, roughly 40 shares are currently held short) or 0.0593% of the tradable shares (for every 100,000 tradable Lucira Health shares, roughly 59 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Lucira Health.

Find out more about how you can short Lucira Health stock.

Lucira Health share dividends

We're not expecting Lucira Health to pay a dividend over the next 12 months.

You may also wish to consider:

Lucira Health overview

Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co. , Ltd. ; technical services agreement with Jabil, Inc.

Frequently asked questions

What percentage of Lucira Health is owned by insiders or institutions?
Currently 3.59% of Lucira Health shares are held by insiders and 50.102% by institutions.
How many people work for Lucira Health?
Latest data suggests 71 work at Lucira Health.
When does the fiscal year end for Lucira Health?
Lucira Health's fiscal year ends in December.
Where is Lucira Health based?
Lucira Health's address is: 1412 62nd Street, EmeryVille, CA, United States, 94608

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site